April 28, 2026
Expanded Catalog: 8 New Research Peptides Now Available
Nexus Compounding has expanded its domestically compounded research peptide catalog with eight new compounds, each independently full-panel tested prior to release.
Nexus Compounding LLC has added eight new research-grade peptides to its catalog, all produced domestically at its Texas-based ISO Class 5 cleanroom facility and independently full-panel tested before lot release.
New Additions
The expanded catalog includes compounds across several research categories, with each lot subjected to the same rigorous testing panel as all existing Nexus products:
- HPLC identity and purity verification (>99% target)
- Endotoxin testing (LAL method)
- Sterility confirmation
- Heavy metals screening
- Residual solvent analysis
Availability
All new compounds are available immediately through the Nexus Compounding online store. Certificate of Analysis documentation is available for each lot via the product page or the QR code shipped with every vial.
Researchers requiring specific lot documentation prior to purchase may contact the Nexus team directly.